US Patent Issued to RepoCeuticals on March 4 for "Compositions for use in the treatment of photosensitivity" (Danish, Spanish Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,727, issued on March 4, was assigned to RepoCeuticals A/S (Horsholm, Denmark).

"Compositions for use in the treatment of photosensitivity" was invented by Lars Otto Uttenthal (Madrid) and Torsten Bjorn (Kvistgard, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions comprising melatonin and/or derivatives thereof for topical application to the skin for use in the treatment of photosensitivity of whatever cause are described."

The patent was filed on Dec. 4, 2019, under Application No. 17/296,874.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HI...